FDA Sets Regulatory Framework for Regenerative Biological Therapies via Cosmetics and Toiletries

22 November 2017

The U.S. Food and Drug Administration (FDA) announced it has completed a final and comprehensive framework to oversee regenerative medical products, including cellular therapies. The cosmetics industry has leveraged these technologies as well, and as medicine and cosmetic treatments become more “personal” in nature, it will be all the more important the industry is aware of where the FDA draws the line for use of these materials.

According to the FDA, the new framework builds upon an existing risk-based regulatory approach in order to clearly describe what products are regulated as drugs, devices and/or biological products.

Read more…

Save time and easily find the methods and the testing suppliers to substantiate your actives and cosmetics claims.

Don't miss our weekly newsletter

* Receive regular news of what's moving the world of preclinical and clinical testing of the Beauty industry

Save time and easily find the methods and test providers to validate your product claims.